Malnutrition
Universal
Screening
BAPEN MUST 5-step protocol · Alternative measurements · NRS-2002 & MNA-SF · GLIM mapping · Setting-specific care plans · ESPEN 2021 targets
MUST Clinical Screening
Malnutrition Universal Screening Tool · All computations are local & private
MUST = BMI Score + Unplanned Weight Loss Score + Acute Disease Effect Score · BAPEN 2003 · NICE CG32 · NRS-2002 Kondrup · MNA-SF Guigoz · GLIM Cederholm 2019 · ESPEN 2021
BMI—
Wt Loss—
Acute—
Total—
Hospital Dietitian
Consultation
ESPEN 2021-aligned nutritional support protocols, ONS optimisation, and MUST monitoring from our clinical team.
Book Consultation →This tool is intended exclusively for use by registered dietitians, nurses, physicians, and other qualified healthcare professionals trained in nutritional screening. It is not suitable for use by patients or the general public without clinical supervision.
MUST is a malnutrition screening tool — not a comprehensive nutritional assessment. A positive screen (score ≥1) should trigger a full dietitian-led nutritional assessment. MUST identifies risk; formal diagnosis of malnutrition requires GLIM or equivalent assessment criteria.
In patients with significant fluid retention (oedema, ascites, pleural effusion), BMI and body weight will overestimate true nutritional status. Use MUAC and clinical assessment. The actual risk may be substantially higher than the MUST score alone indicates.
MUST was primarily validated in UK adult hospital and community populations. Some thresholds (BMI, weight loss) may require adjustment for South Asian, East Asian, and other ethnic groups. GNRI and MNA-SF were validated in specific European elderly cohorts. Apply clinical judgement when using in paediatric (<18 yrs), pregnancy, or diverse ethnic populations.
No patient data is transmitted, stored, or processed on any external server. All computations run locally in the browser. This tool does not constitute or replace a legal medical record.
Frequently Asked Questions — MUST Screening
What is the MUST (Malnutrition Universal Screening Tool)?
MUST is a 3-step malnutrition screening tool developed by BAPEN (Elia M., 2003) and validated in UK hospital, care home, and community settings (Stratton et al., Br J Nutr 2004). It combines a BMI score, an unplanned weight loss score, and an acute disease effect score into a total MUST score from 0 to 6, classifying patients as low, medium, or high nutritional risk.
How is the MUST score calculated?
MUST = BMI Score (0, 1, or 2) + Unplanned Weight Loss Score (0, 1, or 2) + Acute Disease Effect Score (0 or 2). Step 3 never scores 1 — it only applies when the patient is BOTH acutely ill AND has had no or minimal nutritional intake for 5 or more consecutive days. A total of 0 is low risk, 1 is medium risk, and 2 or more is high risk.
What does a MUST score of 2 or more mean?
A MUST score of 2 or more indicates high nutritional risk. Per BAPEN/NICE CG32, this requires immediate referral to a dietitian or nutrition support team, documented nutritional goals, and nutritional support initiated within 24–48 hours. Re-screening frequency depends on setting: weekly in hospital, monthly in care homes, and monthly in the community.
What if I can't measure height or weight directly?
MUST provides validated alternatives: knee height (Chumlea et al. 1988) or demi-span (Bassey 1986) can estimate height when a patient cannot stand; Mid Upper-Arm Circumference (MUAC) can substitute for BMI entirely when neither height nor weight can be obtained — MUAC below 23.5 cm corresponds to a BMI score of 2, while 23.5 cm or above scores 0.
How does oedema or ascites affect the MUST score?
Significant fluid retention (oedema, ascites, pleural effusion) causes weight and BMI to overestimate true nutritional status, so the MUST score may understate actual malnutrition risk. BAPEN recommends using MUAC and clinical assessment instead of weight-based BMI in these patients, and documenting the oedema/ascites in the patient's records.
How often should MUST be repeated?
Re-screening intervals depend on risk level and setting. Hospital: low risk weekly, medium risk weekly (observe 3-day intake), high risk weekly minimum. Care home: low risk monthly, medium risk monthly, high risk weekly initially then monthly. Community: low risk annually (every 3–6 months for high-risk groups), medium risk every 1–3 months, high risk monthly.